Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of 10.62% is 144% above its 5-year average of -24.13%, near the high end of its 5-year range (-137.62%–50.74%).
6328.29% above its 12-month average of -0.17%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -0.24%.
NET PROFIT MARGIN
10.62%
NET PROFIT MARGIN AVG TTM
-0.17%
NET PROFIT MARGIN AVG 3Y
-38.46%
NET PROFIT MARGIN AVG 5Y
-24.13%
NET PROFIT MARGIN AVG 10Y
13.70%
NET PROFIT MARGIN AVG 15Y
18.27%
NET PROFIT MARGIN AVG 20Y
23.02%
CURRENT VS TTM AVG
+6328.29%
CURRENT VS 3Y AVG
+127.62%
CURRENT VS 5Y AVG
+144.01%
CURRENT VS 10Y AVG
-22.51%
CURRENT VS 15Y AVG
-41.87%
CURRENT VS 20Y AVG
-53.86%
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 790 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Caris Life Sciences, Inc.
Market Cap
$8.05B
Net Profit Margin
10.62%
TTM Avg
-0.17%
3Y Avg
-38.46%
5Y Avg
-24.13%
Market Cap
$8.37B
Net Profit Margin
3.60%
TTM Avg
-1.75%
3Y Avg
-5.71%
5Y Avg
-20.27%
Market Cap
$7.66B
Net Profit Margin
0.00%
TTM Avg
-1068.74%
3Y Avg
-1793.84%
5Y Avg
-1195.89%
Market Cap
$7.60B
Net Profit Margin
-1259.87%
TTM Avg
-2041.36%
3Y Avg
-2870.64%
5Y Avg
-2002.71%
Market Cap
$7.60B
Net Profit Margin
15.15%
TTM Avg
-46.46%
3Y Avg
-43.29%
5Y Avg
-43.29%
Market Cap
$7.59B
Net Profit Margin
17.36%
TTM Avg
12.22%
3Y Avg
6.75%
5Y Avg
3.72%
Market Cap
$8.59B
Net Profit Margin
-285.41%
TTM Avg
-634.98%
3Y Avg
-446.89%
5Y Avg
-343.19%
Market Cap
$8.70B
Net Profit Margin
-47.79%
TTM Avg
-8441.28%
3Y Avg
-4260.06%
5Y Avg
-2873.03%
Market Cap
$7.32B
Net Profit Margin
-64.64%
TTM Avg
-52.37%
3Y Avg
-49.29%
5Y Avg
-43.60%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Caris Life Sciences, Inc. (CAI) | $8.05B | 10.62% | -0.17% | -38.46% | -24.13% |
| Oscar Health, Inc. (OSCR)vs › | $8.37B | 3.60% | -1.75% | -5.71% | -20.27% |
| Praxis Precision Medicines, Inc. (PRAX)vs › | $7.66B | 0.00% | -1068.74% | -1793.84% | -1195.89% |
| Cytokinetics, Incorporated (CYTK)vs › | $7.60B | -1259.87% | -2041.36% | -2870.64% | -2002.71% |
| Hinge Health, Inc. (HNGE)vs › | $7.60B | 15.15% | -46.46% | -43.29% | -43.29% |
| HealthEquity, Inc. (HQY)vs › | $7.59B | 17.36% | 12.22% | 6.75% | 3.72% |
| Kymera Therapeutics, Inc. (KYMR)vs › | $8.59B | -285.41% | -634.98% | -446.89% | -343.19% |
| Arrowhead Pharmaceuticals, Inc. (ARWR)vs › | $8.70B | -47.79% | -8441.28% | -4260.06% | -2873.03% |
| Ionis Pharmaceuticals, Inc. (IONS)vs › | $7.32B | -64.64% | -52.37% | -49.29% | -43.60% |
| Protagonist Therapeutics, Inc. (PTGX)vs › | $8.82B | 29.40% | -109.74% | -207.58% | -253.39% |
Operating Margin
5.6%
Net Profit Margin
10.6%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -0.24% |
| 2026-03-31 | -0.24% |
| 2025-12-31 | 27.98% |
| 2025-09-30 | 11.22% |
| 2025-06-30 | -39.58% |
| 2025-03-31 | -84.84% |
| 2024-12-31 | -28.44% |
| 2024-09-30 | -66.65% |
| 2024-06-30 | -66.15% |
| 2024-03-31 | -137.62% |
| 2021-09-30 | 50.74% |
| 2021-06-30 | 44.28% |
| 2021-03-31 | 44.23% |
| 2020-12-31 | 22.15% |
| 2020-09-30 | 19.54% |
| 2020-06-30 | -0.83% |
| 2020-03-31 | -1.27% |
| 2019-12-31 | 7.84% |
| 2019-09-30 | -4.41% |
| 2019-06-30 | 8.84% |
| 2019-03-31 | 16.72% |
| 2018-12-31 | 16.79% |
| 2018-09-30 | 18.84% |
| 2018-06-30 | 19.20% |
| 2018-03-31 | 17.97% |
| 2017-12-31 | 38.88% |
| 2017-09-30 | 19.51% |
| 2017-06-30 | 15.28% |
| 2017-03-31 | 6.47% |
| 2016-12-31 | 0.63% |
| 2016-09-30 | -6.90% |
| 2016-06-30 | 5.24% |
| 2016-03-31 | 10.70% |
| 2015-12-31 | -19.15% |
| 2015-09-30 | 19.65% |
| 2015-06-30 | 21.71% |
| 2015-03-31 | 23.15% |
| 2014-12-31 | 27.48% |
| 2014-09-30 | 27.69% |
| 2014-06-30 | 24.31% |
| 2014-03-31 | 26.30% |
| 2013-12-31 | 28.58% |
| 2013-09-30 | 28.46% |
| 2013-06-30 | 31.95% |
| 2013-03-31 | 31.53% |
| 2012-12-31 | 34.92% |
| 2012-09-30 | 36.78% |
| 2012-06-30 | 39.72% |
| 2012-03-31 | 37.93% |
| 2011-12-31 | 35.57% |
| 2011-09-30 | 41.33% |
| 2011-06-30 | 37.83% |
| 2011-03-31 | 46.13% |
| 2010-12-31 | 41.62% |
| 2010-09-30 | 45.53% |
| 2010-06-30 | 32.69% |
| 2010-03-31 | 20.07% |
| 2009-12-31 | 20.07% |
| 2009-09-30 | 20.33% |
| 2009-06-30 | 20.00% |
| 2009-03-31 | 22.50% |
| 2008-12-31 | -195.33% |
| 2008-09-30 | 26.62% |
| 2008-06-30 | 30.35% |
| 2008-03-31 | 29.96% |
| 2007-12-31 | 32.38% |
| 2007-09-30 | 30.94% |
| 2007-06-30 | 29.29% |
| 2007-03-31 | 24.89% |
| 2006-12-31 | 21.89% |
| 2006-09-30 | 29.92% |
| 2006-06-30 | 26.02% |
| 2006-03-31 | 17.19% |
